Welcome to The Skipton Fund

The Skipton Fund is an ex gratia payment scheme that makes payments to certain people who were infected with hepatitis C through treatment with NHS blood or blood products prior to September 1991 in England, Wales or Northern Ireland and other persons eligible for payment in accordance with the scheme's provisions.


Replacement of the Skipton Fund from 1 November

The Government has announced that from 1 November 2017 there will be new scheme administrators replacing the Skipton Fund for applications emanating from hepatitis C infection in England, Northern Ireland and Wales. The NHS Business Services Authority (BSA) will be the new scheme administrator in England; the Northern Ireland Regional Business Services Organisation (BSO) will be the new scheme administrator in Northern Ireland; and  the Velindre NHS Trust will be the new scheme administrator in Wales. The Skipton Fund will no longer be processing applications from 1 November 2017. 

Due to the length of time it takes to complete a new application, the Fund will therefore be unable to accept new registrations from 4 October 2017.  Contact details for the new schemes will be made available on this website once they become available and new applicants should register with the relevant scheme at that time.

For applications emanating from hepatitis C infection in Scotland, applications are being administered by NHS National Services Scotland. Please click on this link to access their website.


The History of the Skipton Fund

The Skipton Fund was established on 25 March 2004 by the Department of Health (England), acting for and on behalf of the Secretary of State for Health, the Scottish Ministers, the National Assembly for Wales and the Department of Health, Social Services and Public Safety (Northern Ireland) (together "the UK health administrations"), to administer the scheme and make payments to relevant claimants on behalf of each of the UK health administrations.

Scottish Ministers adopted the Skipton Fund as a scheme under section 28 (Infection with hepatitis C as a result of NHS treatment etc) of the Smoking, Health and Social Care (Scotland) Act 2005. However, from 1 April 2017, new and existing applications emanating from Scotland will be administered by a new dedicated Scottish scheme called the Scottish Infected Blood Support Scheme (SIBSS). In order for the Skipton Fund to pass details of an existing applicant to SIBSS we will first need their signed consent. Please contact the Skipton Fund for further details. 

For full news articles please click here

Xem phim sex

Increase to stage 1 and 2 regular payments from April 2017 Thursday 15th June 2017

The Department of Health has confirmed that from 1 April 2017, the Skipton Fund stage 1 and 2 regular payments and winter fuel payment will be increased by 1% in line with the Consumer Prices Index (CPI) for those receiving payments from the schemes in England and Northern Ireland.

The annual sum payable for stage 1 is now £3,030, which equates to monthly payments of £252.50 or quarterly payments of £757.50. The winter fuel payment is now £505 which will be paid as a lump sum in winter.

The annual sum payable for stage 2 is now £15,150, which equates to monthly payments of £1,262.50 or quarterly payments of £3,787.50. The winter fuel payment is now £505 which will be paid as a lump sum in winter.

The regular payments in Wales will remain at £3,000 per year for stage 1 and £15,000 per year for stage 2 due to the announced increase to these payments that will be payable through the new scheme in Wales from 1 October 2017.

The monthly payment in June 2017 will include the backdated increase for April and May 2017 and the quarterly payment in July 2017 will include the backdated increase for April to June 2017.

 

Register
If you believe you qualify for a Skipton Fund payment, you may register online now.

Register

Frequently Asked Questions
A: To qualify for a Skipton Fund payment you must have been infected with Hepatitis C as a result of treatment from NHS blood or blood products prior to September 1991.